European Disease Progression Monitor: Edition 5

European Disease Progression Monitor: Edition 5

COVID-19 EU progression monitor

lockdown exit strategies in EU

lockdown transition plan

COVID-19 death rate EU

tracking the pandemic

control phase

French data

U.K. numbers have stabilised

Overview of treatments

Disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition 4

Sign-up here to receive Disease Progression Monitor updates.

Sign-up

Related Insights

Strategy

COVID-19

Global Situation Report Insights: Edition 2

June 9, 2020

The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.

Life Sciences & Pharma

Video

A Tale of Two Markets: Precision Medicine in China and Japan

March 2, 2020

L.E.K.’s Alex Vadas gives his take on precision medicine in China and Japan.

Digital

Executive Insights

Automation and Jobs: Why CEOs Must Prepare for Structural Change

March 11, 2020

In 2017, L.E.K. Consulting’s Executive Insights “Jobs for the Bots” reviewed the Office of National Statistics (ONS) data on the UK labour market,…

Organization & Performance

COVID-19

Agile Transformation Part 2: Tackling the Challenges of Scaling

May 14, 2020

We share our experience of working with large corporations to develop and execute agile transformation programmes

Life Sciences & Pharma

Executive Insights

AI in Biopharma: Realizing the Promise

October 31, 2019

Artificial intelligence (AI) should enable biopharma companies to tackle the entrenched inefficiencies of the costly and time-consuming drug development…

Life Sciences & Pharma

Video

Medical Affairs

March 17, 2020

Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function.